Título:
|
Cost avoidance and outcome improvement by implementing a test utilization strategy for molecular microbiology tests
|
Autores:
|
Ricaldi, J. ;
Racsa, L. ;
Pusch, T. ;
Gander, R.M. ;
Southern, P. ;
Cavuoti, D. ;
Byrd, L. ;
Alatoom, A.
|
Tipo de documento:
|
texto impreso
|
Editorial:
|
Elsevier, 2020-06-10T18:11:34Z
|
Nota general:
|
info:eu-repo/semantics/restrictedAccess
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
|
Idiomas:
|
Inglés
|
Palabras clave:
|
Editados por otras instituciones
,
Artículos
,
Artículos en revistas indizadas
|
Resumen:
|
Test utilization is an essential strategy in the clinical laboratory, especially with increasing numbers of tests and health care costs. We designed a triage system for molecular microbiology tests ordered from 2007 through 2010 to assess their appropriateness before they were sent out to a reference laboratory for testing. The number of tests ordered and approved and the number with positive results were calculated during the study period. Cost avoidance was subsequently calculated. A total of 13,839 tests were ordered, averaging 3,335 tests/year. The overall approval rate was 76%, ranging from 72% in 2007 to 81% in 2010. With the exception of cytomegalovirus (CMV) and BK virus PCR, the numbers of all tests decreased in 2010 compared to 2007. The total savings over 4 years was $374,791, with an average cost avoidance of $93,698/year. Pathologists and microbiologists should design a utilization system for laboratory testing to avoid unnecessary cost and improve patient care. © 2014 Elsevier Inc..
|
En línea:
|
http://doi.org/10.1016/j.clinmicnews.2014.11.004
|